Press Releases from Focal Segmental Glomerulosclerosis (FSGS) Therapeutics - Pharma Proff (1 total)
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics - Pipeline Analysis 2018
Focal segmental glomerulosclerosis (FSGS) is a glomerular disease, which is characterized by scarring or sclerosis in the kidney. Scarring damages the limited number of glomeruli…
Go To Page:
